Document is current
Any future updates will be listed below
-
Authors
Tremblay, Frederic https://orcid.org/0009-0003-1237-3752
Xiong, Qiang
Shah, Shrijal S.
Ko, Chih-Wei
Kelly, Kenneth
Morrison, Mary S.
Giancarlo, Cristiana
Ramirez, Ricardo N.
Hildebrand, Erica M. https://orcid.org/0000-0001-7625-8997
Voytek, Sarah B.
El Sebae, Gabriel K.
Wright, Shane H.
Lofgren, Liam
Clarkson, Scott
Waters, Christine
Linder, Samantha J.
Liu, Songlei
Eom, Taesun
Parikh, Shefal
Weber, Yuki
Martinez, Salette
Malyala, Padma
Abubucker, Sahar
Friedland, Ari E. https://orcid.org/0000-0003-4983-1801
Maeder, Morgan L.
Lombardo, Angelo https://orcid.org/0000-0001-8262-042X
Myer, Vic E.
Jaffe, Aron B. https://orcid.org/0000-0002-6220-0476
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 13 January 2025
First Online: 10 February 2025
Competing interests
: F.T., Q.X., S.S.S., C.-W.K., K.K., M.S.S., C.G., R.N.R., E.M.H., S.B.V., G.K.E., S.H.W., L.L., S.C., C.W., S.J.L., S.L., T.E., S.P., Y.W., S.M., P.M., S.A., A.E.F., M.L.M., V.E.M. and A.B.J. were employees of Chroma Medicine and held an equity interest in Chroma Medicine at the time the work was conducted. A.L. is a founder of and holds an equity interest in Chroma Medicine. Chroma Medicine has filed for patent protection related to various aspects of epigenetic editing of PCSK9, with S.A., A.E.F., M.L.M., V.E.M., F.T. and M.S.S. as the inventors.
